P1321 : A phase 3B, double blind, placebo controlled study evaluating the effect of obeticholic acid on clinical outcomes in subjects with primary biliary cirrhosis at elevated risk of progression to liver transplant or death

Autor:	Keith D. Lindor, Bettina E. Hansen, T. Marmon, D.E.J. Jones, R. Pencek, David Shapiro, R. Hooshmand-Rad, Leigh MacConell
Rok vydání:	2015
Předmět:	medicine.medical_specialty Hepatology business.industry Placebo-controlled study Obeticholic acid medicine.disease Gastroenterology Surgery Double blind chemistry.chemical_compound Primary biliary cirrhosis chemistry Internal medicine medicine business
Zdroj:	Journal of Hepatology. 62:S850-S851
ISSN:	0168-8278
DOI:	10.1016/s0168-8278(15)31500-2
Databáze:	OpenAIRE
Externí odkaz:	https://explore.openaire.eu/search/publication?articleId=doi_________::e983db6deb3f75d63a4efdcf1636e23c https://doi.org/10.1016/s0168-8278(15)31500-2 Zobrazit plný text záznamu Full Text from ScienceDirect